Navigation Links
IMD Companies, Inc. (ICBU) Announces Procedure for Issuance of Positive Solutions Stock
Date:2/7/2013

TAMPA, Fla., Feb. 7, 2013 /PRNewswire/ -- IMD Companies, Inc. (ICBU) announces that it has published the procedure for the issuance of Positive Solutions Inc. on the company's websites.  All shareholders of record of ICBU stock on August 17, 2012, will receive one share of Positive stock for every two shares of ICBU stock held.

The shares of Positive Solutions, a privately held Florida corporation, were issued to ICBU in exchange for the spin-off of the subsidiary last June. ICBU's Board of Directors approved a resolution to issue the shares on a one for two basis. Positive Solutions has been engaged in negotiations for potential acquisitions with various medical and non-medical companies as a platform to expand its activities in the industry, and is hopeful that a completed merger can be announced currently. "We are hopeful that these shares will represent a valuable asset not only for ICBU going forward, but for our shareholders that received the issuance as well," stated ICBU CEO Bruce Collette .

ABOUT IMD Companies, Inc.

IMD Companies, Inc., (OTC MARKETS:ICBU) is a Florida corporation, engaged in the medical diagnostics and health and fitness industries. Its primary products and services lie in the health and fitness nutraceutical and medical diagnostics services markets. The company has also expanded into the weight-loss industry.  The company delivers its medical diagnostic services on-site at participating medical clinics and physician offices. The nutraceutical supplements, pills, bar and gels will be marketed and distributed through participating clinics and on-line web marketing retail methods.  The company will continue to develop its innovative marketing strategies, including the use of social networking vehicles.

Safe Harbor Statement:

Certain statements made in this press release constitute forward-looking statements that are based on management's expectations, estimates, projections and assumptions. Words such as "expects," "anticipates," "plans," "believes," "scheduled," "estimates" and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors. All forward-looking statements speak only as of the date of this press release and the company does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.

www.imdcompanies.com


'/>"/>
SOURCE IMD Companies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Par Pharmaceutical Companies, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By TPG
2. Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Par Pharmaceutical Companies, Inc.
3. IMD Companies, Inc. (ICBU) looks to future and adapts
4. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
5. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
6. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
7. Misonix Announces New Distribution Agreement For Panama
8. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
9. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
10. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
11. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2017)... Aug. 3, 2017  Agragen, LLC, a ... in the biopharmaceutical, nutraceutical, and aquacultural feed sectors, ... its lead drug candidates, AGR131.  This drug is ... from the blood of patients suffering from inflammatory ... bowel disease. ...
(Date:8/2/2017)... and BENTON, Ky. , Aug. 2, 2017   Marshall County ... its environmental services (ES) team to proactively reduce the risk of hospital-acquired infections (HAIs). The ... disinfection robot that uses UVC light energy to kill deadly pathogens such as C. ... Tru-D SmartUVC ... Tru-D in action in ...
(Date:8/1/2017)... , Aug. 1, 2017   CerSci Therapeutics ... Dallas, Texas , has received notice from ... National Institutes of Health (NIH) that it has been ... grant totaling over $650,000 in 2017 with an additional ... CerSci,s Investigational New Drug application of their lead non-opioid ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... August 16, 2017 , ... Richard Strawn’s new ... during the time of a cancer diagnosis, surgery and recovery, the Psalms provided ... the many ways God shows love to those who are sick., Surgical Psalms ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... an opportunity for men and women to train as hospice volunteers. Volunteers provide ... life-limiting illness. For over 30 years, the agency has trained volunteers to be ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... ... leading manufacturers and marketers of high-quality anti-aging skincare solutions, recently announced the launch ... new products are an affordable, yet effective alternative to expensive plastic surgery or ...
(Date:8/16/2017)... ... ... The Eyes of A Child” is the creation of published author, Pauline DiBenedetto. , “As ... Since she was in such great pain, my mother thought that her time has come. ... wasn’t until I was about eight years old, when I had a vision of my ...
(Date:8/15/2017)... ... August 15, 2017 , ... The first study to report ... myeloma has been completed, with the team’s findings now published online ahead of print ... Director of the Blood and Marrow Transplant Program at Roswell Park Cancer Institute, was ...
Breaking Medicine News(10 mins):